Atherton Lane Advisers’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$33M Buy
275,830
+7,798
+3% +$902K 1.92% 14
2015
Q3
$29M Buy
268,032
+45,852
+21% +$5.69M 1.81% 15
2015
Q2
$25.7M Buy
222,180
+6,400
+3% +$732K 1.42% 25
2015
Q1
$24.9M Buy
215,780
+2,437
+1% +$291K 1.34% 32
2014
Q4
$23.9M Buy
213,343
+757
+0.4% +$79.8K 1.31% 33
2014
Q3
$20.1M Buy
212,586
+8,760
+4% +$791K 1.15% 40
2014
Q2
$17.5M Buy
203,826
+26,104
+15% +$1.99M 0.97% 53
2014
Q1
$12.4M Buy
177,722
+5,672
+3% +$449K 0.77% 60
2013
Q4
$14.5M Buy
172,050
+1,130
+0.7% +$89.4K 0.92% 57
2013
Q3
$13.2M Sell
170,920
-3,050
-2% -$214K 0.9% 61
2013
Q2
$10.2M Buy
+173,970
New +$10.5M 0.74% 59

Other funds holding CELG

Atherton Lane Advisers's CELG Position: Q4 2015 in Review

Atherton Lane Advisers increased its Celgene Corp (CELG) stake by 2.9% in Q4 2015, buying an estimated $902K and bringing the position to 275,830 shares worth $33M. The position accounts for 1.92% of the portfolio, ranked #14.

Atherton Lane Advisers first reported a position in CELG in Q2 2013 and has held it in 11 quarters since. 1,246 funds tracked by Wall St. Rank hold CELG as of Q4 2015.

  • Atherton Lane Advisers held 275,830 shares of Celgene Corp worth $33M as of Q4 2015.
  • Atherton Lane Advisers bought 7,798 Celgene Corp shares in Q4 2015, an estimated $902K.
  • Celgene Corp made up 1.92% of Atherton Lane Advisers's portfolio in Q4 2015, its #14 holding.
  • Atherton Lane Advisers first reported a position in Celgene Corp in Q2 2013 and has held it in 11 quarters since.
  • 1,246 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2015.

Based on Atherton Lane Advisers's 13F filing for Q4 2015, filed 16 Feb 2016.